Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-23

Clinical Trial Update: Does Topical Ophthalmic Proparacaine 0.5% Prior to Probing and Irrigation Decrease Pain? [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether topical proparacaine before probing and irrigation reduces pain in patients with tear drainage disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Proparacaine 0.5% (proparacaine)

Snippet

Sponsor: Louisiana State University Health Sciences Center in New Orleans | Conditions: Epiphora, Dacryostenosis | Phase 4 | Status: RECRUITING